Johnson & Johnson vs First Trust NASDAQ 100 Technology Index Fund — how do they compare? Johnson & Johnson trades at $260.21 (market cap $626.09B), while First Trust NASDAQ 100 Technology Index Fund trades at $320.56. The key difference: Johnson & Johnson pays a 2.06% dividend while First Trust NASDAQ 100 Technology Index Fund pays none. Which is the better fit depends on your goals.
| JNJ | QTEC | |
|---|---|---|
Market Cap | $626.09B | — |
Volume | 6,156,228 | — |
Sector | Health | Broad Market / Factor |
52-Week High | $267.24 | $335.74 |
52-Week Low | $172.78 | $207.03 |
Enterprise Value | $654.37B | — |
Dividend Yield | 2.06% | — |
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $261.26, down 0.21% on the day, near its 52-week high. The stock shows a bullish technical trend with strong moving averages and recent earnings beats. Revenue grew to $94.19B in 2025, with a net income margin of 21.48%, though cash flow turned negative due to heavy investing. The company maintains a robust dividend history, with consistent payouts and a 64-year growth streak.
Outlook remains positive with a consensus price target of $284.50, offering ~9% upside. Risks include legal headwinds and patent expirations, but analyst sentiment is bullish (52.5% buy ratings). JNJ's defensive profile and pipeline strength support long-term growth, though investors should monitor debt levels, which rose to 24.06% of assets in 2025.
QTEC trades at $320.61, up 1.51% today, with a bullish technical signal driven by strong moving average alignment. The ETF, tracking NASDAQ-100 technology stocks, lacks disclosed fundamental ratios but benefits from broad tech sector exposure. Recent news highlights its role in technology equity access, with a dividend scheduled for June 2026.
Outlook remains tied to technology sector performance, offering growth potential amid innovation trends. Risks include market volatility and sector concentration. Analyst sentiment is positive, but investors should weigh tech cyclicality against long-term growth prospects.
Trailing returns across standard periods
Latest headlines on both assets
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →QTEC is an ETF that seeks to track the performance of the NASDAQ-100 Technology Sector Index. The fund provides targeted exposure to companies within the NASDAQ-100 that are classified as technology or telecommunications companies, focusing on firms involved in software, hardware, and related services. QTEC is a tool for investors seeking focused exposure to high-growth, large-cap technology companies listed on the NASDAQ exchange.
Read more on QTEC →